Was gibt es Neues bei Carotisendarteriektomie und Carotisstenting?

This article refers to current study results on carotid revascularisation and provides evidence-based therapy recommendations. Key findings include the following. Follow-up after carotid intervention is of great importance for long-term outcome. Chronological age should not be considered a contraindication to carotid endarterectomy (CEA). Perioperative outcome is significantly worse in patients without best medical treatment (BMT, platelet aggregation inhibitors and statins) than in patients with BMT. Data recommend bovine pericardial patch closure or eversion endarterectomy (EEA). For patients with a previous heart attack, CEA and transcarotid arterial revascularisation (TCAR) are the preferred treatment options. Results after TCAR and CEA in registries are largely comparable . In patients with hostile neck, TCAR is significantly superior to transfemoral carotid stenting (TFCAS). In TFCAS, distal embolic protection filters should be routinely used . Patients with carotid stenting should receive dual platelet aggregation inhibitors for 3 days prior to surgery.